lacosamide oral solution
Generic: lacosamide
Labeler: ajenat pharmaceuticals llcDrug Facts
Product Profile
Brand Name
lacosamide oral solution
Generic Name
lacosamide
Labeler
ajenat pharmaceuticals llc
Dosage Form
SOLUTION
Routes
Active Ingredients
lacosamide 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
82983-427
Product ID
82983-427_9fd5f392-f470-4f19-96da-582fae4da496
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA219699
DEA Schedule
cv
Listing Expiration
2026-12-31
Marketing Start
2025-07-14
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
82983427
Hyphenated Format
82983-427
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lacosamide oral solution (source: ndc)
Generic Name
lacosamide (source: ndc)
Application Number
ANDA219699 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 200 mL in 1 BOTTLE, PLASTIC (82983-427-31)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9fd5f392-f470-4f19-96da-582fae4da496", "openfda": {"nui": ["N0000008486"], "upc": ["0382983427310"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["cb29da34-89aa-405a-8fbc-2308bda37187"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Ajenat Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "200 mL in 1 BOTTLE, PLASTIC (82983-427-31)", "package_ndc": "82983-427-31", "marketing_start_date": "20250714"}], "brand_name": "Lacosamide Oral Solution", "product_id": "82983-427_9fd5f392-f470-4f19-96da-582fae4da496", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "82983-427", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Ajenat Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide Oral Solution", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA219699", "marketing_category": "ANDA", "marketing_start_date": "20250714", "listing_expiration_date": "20261231"}